The short version of thymosin beta-4 fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
==== The SEIR model with vital dynamics and constant population ==== As described in the example above, so many epidemic processes can be described with a SIR model. However, for many important infections, such as COVID-19, there is a significant latency period during which individuals have been infected but are not yet infectious themselves. During this period the individual is in compartment E (for exposed). Here, the formation of the next-generation matrix from the SEIR model involves determining two compartments, infected and non-infected, since they are the populations that spread the infection. So we only need to model the exposed, E, and infected, I, compartments. Consider a population characterized by a death rate
=== July === 1 July: The Government's Healthy Homes standards come into effect, parental leave payments increase, Jobseeker welfare beneficiaries will need to reapply every six months, the Government's KiwiSaver contributions drop from 50 cents to 25 cents per dollar, ACC payments increase by 2.89%, and public transport fares rise nationwide. Farms will be required to keep raw milk records in order to combat the spread of mycoplasma bovis. The weight loss drug Semaglutide (Wegovy) becomes available in New Zealand. Justice Minister Paul Goldsmith and Associate Justice Minister Nicole McKee announce several tougher penalties that they claim will combat shoplifting. 2 July — The New Zealand Space Agency confirms that contact with the emissions-monitoring satellite MethaneSAT had been lost on 20 June and that recovery was unlikely. The New Zealand Government had contributed NZ$29 million to the US-based Environmental Defense Fund's MethaneSAT, which was tasked with monitoring oil and gas emissions. 3 July: Goldsmith and McKee announce longer periods and fines for trespassing. Local authorities extended the state of emergency in Nelson, Tasman and Marlborough for another seven days in response to forecast heavy rain. A severed fiber-optic cable causes mobile phone and power outages in Golden Bay, Tasman. A line fault causes power outages to 2,000 properties in the Selwyn District including Rolleston and Templeton. Torrential rain leads to flooding, landslips, sewage overflows and evacuations in parts of Taranaki including New Plymouth.
=== Optical methods === Directed assembly or more specifically directed self-assembly, can produce a high pattern resolution (~10 nm) with high efficiency and compatibility. However, when using DSA in high volume manufacturing, one must have a way to quantify the degree of order of line/space patterns formed by DSA in order to reduce defect. Normal approaches, such as critical dimension-scanning electron microscopy (CD-SEM), to obtain data for pattern quality inspection take too much time and is also labor-intensive. On the other hand, the optical scatterometer-based metrology is a non-invasive technique and has very high throughput due to its larger spot size. These result in the collection of more statistical data than by using SEM, and that data processing is also automated with the optical technique making it more feasible than traditional CD-SEM.
== Cited literature == Bilstein, Roger E. (1996). Stages to Saturn: A Technological History of the Apollo/Saturn Launch Vehicles. Washington: Scientific and Technical Information Branch, National Aeronautics and Space Administration. ISBN 0-16-048909-1. Burgess, Colin; Hall, Rex (2009). The First Soviet Cosmonaut Team. Chichester, UK: Praxis Publishing. ISBN 978-0-387-84824-2. LCCN 2008935694. Burgess, Colin; Kate Doolan; Bert Vis (2003). Fallen Astronauts: Heroes Who Died Reaching for the Moon. Lincoln: University of Nebraska Press. ISBN 0-8032-6212-4. Brzezinski, Matthew (2007). Red Moon Rising: Sputnik and the Hidden Rivalries that Ingnited the Space Race. New York: Times Books, Henry Holt and Company. ISBN 978-0-8050-8147-3. Burrows, William E. (1998). This New Ocean: The Story of the First Space Age. New York: Random House. ISBN 978-0-679-44521-0. Cadbury, Deborah (2006). Space Race: The Epic Battle Between America and the Soviet Union for Dominance of Space. New York: Harper Collins Publishers. ISBN 978-0-06-084553-7. Chaikin, Andrew (1994). A Man on the Moon: The Triumphant Story of the Apollo Space Program. New York: Penguin Books. ISBN 0-14-027201-1. Chertok, Boris (2005). Rockets and People Volumes 1-4. National Aeronautics and Space Administration. Retrieved May 29, 2022. Cornwell, John (2003). Hitler's Scientists: Science, War, and the Devil's Pact. New York: Viking Press. ISBN 0-670-03075-9. Dallek, Robert (2003). An Unfinished Life: John F. Kennedy, 1917–1963. Boston: Little, Brown and Company. ISBN 0-316-17238-3. Leonard, David (2019). Moon Rush.
Sources: en.wikipedia.org
=== Therapy of oral lichen planus === Oral lichen planus (OLP) is a chronic inflammatory T- cellular disorder that strikes the oral mucosa. In a clinical report in 2022, a fast resolving of OLP was achieved in a patient treated with Abrocitinib. A dose of 200 mg of Abrocitinib was administered daily as monotherapy for twelve weeks. A constant improvement of lesions, a depletion of Wickham striae, and a disappearance of erosions were observed at weeks four and eight of treatment. At week twelve, there was a total recovery of the right buccal mucosa. No adverse events have occurred during the treatment and Abrocitinib was well tolerated by the patient.
===== Sixth generation ===== Sixth generation breast implants were introduced in the early 2010s to address some of the issues seen in previous generations. They feature a smoother surface that is designed to minimize the body's inflammatory response and reduce the risk of a foreign body reaction. These implants use a newer, biomimetic topography that helps to reduce bacterial growth and inflammation compared to the earlier macro-textured devices. Additionally, they incorporate other advancements, such as ergonomic gels that change shape depending on body position and advanced multi-layered shells to reduce the diffusion of silicone. Some manufacturers have also introduced lightweight alternatives that use hollow microspheres mixed with silicone gel to make the implants lighter for a given volume. This has led to improved results, with studies showing that the implants form thinner capsules and cause less inflammation than their predecessors.
== Awards == 2013, International Society for Molecular Recognition (ISMR) 2015, Janne Carlsson's prize for academic leadership, KTH 2022, The Westrup prize, The Royal Physiographic Society of Lund 2022, Alum of the Year, KTH
Sources: en.wikipedia.org
The heart functions as a pump in the circulatory system to provide a continuous flow of blood throughout the body. This circulation consists of the systemic circulation to and from the body and the pulmonary circulation to and from the lungs. Blood in the pulmonary circulation exchanges carbon dioxide for oxygen in the lungs through the process of respiration. The systemic circulation then transports oxygen to the body and returns carbon dioxide and relatively deoxygenated blood to the heart for transfer to the lungs. The right heart collects deoxygenated blood from two large veins, the superior and inferior venae cavae. Blood collects in the right and left atrium continuously. The superior vena cava drains blood from above the diaphragm and empties into the upper back part of the right atrium. The inferior vena cava drains the blood from below the diaphragm and empties into the back part of the atrium below the opening for the superior vena cava. Immediately above and to the middle of the opening of the inferior vena cava is the opening of the thin-walled coronary sinus. Additionally, the coronary sinus returns deoxygenated blood from the myocardium to the right atrium. The blood collects in the right atrium. When the right atrium contracts, the blood is pumped through the tricuspid valve into the right ventricle. As the right ventricle contracts, the tricuspid valve closes and the blood is pumped into the pulmonary trunk through the pulmonary valve.
The bite of the larger European vipers may be very dangerous, and followed by fatal results, especially in children, at least in the hotter parts of the Continent; whilst the small meadow viper (Vipera ursinii), which hardly ever bites unless roughly handled, does not seem to be possessed of a very virulent venom, and although very common in some parts of Austria and Hungary, is not known to have ever caused a serious accident.
11-Deoxycortisol in mammals has limited biological activity and mainly acts as metabolic intermediate within the glucocorticoid pathway, leading to cortisol. However, in sea lampreys, an early jawless fish species that originated over 500 million years ago, 11-deoxycortisol is the primary and ultimate glucocorticoid hormone with mineralocorticoid properties; 11-deoxycortisol also takes part, by binding to specific corticosteroid receptors, in intestinal osmoregulation in sea lamprey at metamorphosis, during which they develop seawater tolerance before downstream migration. Sea lampreys do not possess the 11β-hydroxylase enzyme (CYP11B1) responsible for converting 11-deoxycortisol to cortisol and 11-deoxycorticosterone to corticosterone, as observed in mammals. The absence of this enzyme in sea lampreys indicates the existence of a complex and highly specific corticosteroid signaling pathway that emerged at least 500 million years ago with the advent of early vertebrates. The lack of cortisol and corticosterone in sea lampreys suggests that the presence of the 11β-hydroxylase enzyme may have been absent during the early stages of vertebrate evolution. The absence of cortisol and corticosterone in sea lampreys suggests that the 11β-hydroxylase enzyme may not have been present early in vertebrate evolution.
====== Blotters ====== Blotter art designs printed on blotter paper can identify dose strengths, different batches, or makers. On the other hand, blotters without art may be considered safer by some, since there is no guarantee that the printer ink used in clandestine production is edible or non-toxic for long-term exposure, and it is also possible for unscrupulous dealers to mimic reputable blotter art designs to boost sales.
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
Sealed, dry and protected from light at reduced temperature is the usual laboratory convention. Allowing a cold vial to reach room temperature before opening limits condensation. Repeated opening exposes the powder to moisture and should be minimised.